Methicillin-resistant Staphylococcus aureus (MRSA) ESBL-producing Enterobacteriaceae (extended-spectrum β-lactamases) Vancomycin-resistant Enterococcus (VRE) Multidrug-resistant Pseudomonas aeruginosa.
we have done a research on the effectiveness of sliver nanoparticle on MRSA.
do you have any recommendations on what is the best route to take I would love to hear your opinio.